ANTITUBERCULAR ANTIBIOTICS / ANTILEPROSY

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/71

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

72 Terms

1
New cards

Dapsone

What is the sulfone derivative of sulfanilamide that was later investigated clinically?

2
New cards

Due to its high dosing, which caused toxicity.

Why was Dapsone considered too toxic for clinical use despite being effective for leprosy?

3
New cards

Streptomycin

What was the first antitubercular aminoglycoside discovered by Waksman et al. in 1944?

4
New cards

p-Aminosalicylic acid (PAS)

Which antitubercular drug’s properties were discovered shortly after streptomycin?

5
New cards

Isoniazid

What key antitubercular drug was discovered in 1952?

6
New cards

Ethambutol
Rifampicin

Which additional antitubercular drugs were later discovered after isoniazid?

7
New cards

Because Mycobacterium leprae fails to grow in cell culture.

Why has the development of drugs for leprosy treatment been difficult?

8
New cards

The availability of animal models, such as the infected mouse footpad.

What recent advancement allows in vivo drug evaluations for leprosy?

9
New cards

Due to the increasing emergence of dapsone-resistant strains of M. leprae.

Why have public health officials advocated for combination therapy in leprosy treatment?

10
New cards

Atypical Mycobacteria

- Mycobacteria other than M. tuberculosis and M. leprae that can cause disease.
- Such organisms are not normally considered particularly virulent or infectious

11
New cards

Increased numbers of immunocompromised individuals

Why are diseases caused by atypical mycobacteria increasing?

12
New cards

- Similar geographical distributions
- Are difficult to distinguish microbiologically and diagnostically

Why are Mycobacterium avium and Mycobacterium intracellulare considered a single complex (MAC)?

13
New cards

Mycobacterium avium
Mycobacterium intracellulare

Considered single complex (MAC)

14
New cards

Tuberculosis

What disease does MAC initially resemble?

15
New cards

Overwhelming disseminated form, leading to high morbidity and mortality.

How does MAC affect HIV-infected individuals?

16
New cards

Mycobacterium kansasii

- Is another atypical mycobacterium that causes pulmonary disease, which can spread (disseminate) in immunocompromised patients.
- Unlike MAC infections, which are resistant to most chemotherapeutic agents, these infections can usually be treated effectively with combinations of antitubercular drugs.

17
New cards

Mycobacterium avium
Mycobacterium intracellulare
Mycobacterium kansasii

Examples of Atypical Mycobacterium

18
New cards

Rifampin

What major antibiotic advanced tuberculosis treatment?

19
New cards

Isoniazid and ethambutol (or pyrazinamide)

What drugs are combined with rifampin for tuberculosis treatment?

20
New cards

At least 2 years

How long was TB maintenance therapy without rifampin?

21
New cards

6 to 9 months

How long is TB therapy with the rifampin combination?

22
New cards

- Isoniazid (H)
- Rifampicin (R)
- Pyrazinamide (Z)
- Ethambutol (E)
- Streptomycin (S)

First-line Anti-TB Agents:

23
New cards

- Cycloserine
- Kanamycin
- Capreomycin
- Ethionamide
- p-aminosalicylic acid (PAS)

Second-line Anti-TB Agents:

24
New cards

2HRZE/4HR
Lungs

Regimen 1 and its Site of Action

25
New cards

2HRZE/10HR
Different Parts of the Body

Regimen 2 and its Site of Action

26
New cards

Bacteriologically confirmed rifampicin-resistant TB (BC RR-TB)

Trends of Resistance
Positive for MTB using rapid diagnostic modalities with resistance to rifampicin.

27
New cards

Bacteriologically confirmed multidrug-resistant TB (BC MDR-TB)

Trends of Resistance
Positive for MTB complex with resistance to at least both isoniazid and rifampicin from an NTP-recognized laboratory.

28
New cards

Bacteriologically confirmed extensively drug-resistant TB (XDR-TB)

Trends of Resistance
Positive for MTB complex with resistance to any fluoroquinolone (FQ) and to at least one second-line injectable drug (streptomycin/ amikacin), in addition to multidrug resistance from an NTP- recognized laboratory.

29
New cards

Isoniazid

Antitubercular Agents: 1st Line
- Prepared by reacting the methyl ester of isonicotinic acid with hydrazine
- Its activity is manifested on the growing tubercle bacilli and not on resting forms
- Bactericidal; causes the bacilli to lose lipid content

<p><strong><em>Antitubercular Agents: 1st Line</em></strong><br>- Prepared by reacting the methyl ester of isonicotinic acid with hydrazine<br>- Its activity is manifested on the growing tubercle bacilli and not on resting forms<br>- Bactericidal; causes the bacilli to lose lipid content</p>
30
New cards

Inhibits the synthesis of mycolic acids, essential components of mycobacterial cell walls.

MOA of Isoniazid

31
New cards

- Isonicotinic acid hydrazide
- Isonicotinyl hydrazide
- INH

Isoniazid is also known as?

32
New cards

Lipid

What is important to mycobacterium tuberculosis (cell wall” peptidoglycan)?

33
New cards

Pyridoxine (vitamin B6)

What supplement is coadministered with isoniazid to prevent peripheral neuritis?

34
New cards

Antagonism of the coenzyme action of pyridoxal phosphate.

What causes peripheral neuritis in isoniazid therapy?

35
New cards

Hepatotoxicity

Which toxic reaction is more common when isoniazid is combined with rifampin?

36
New cards

Acetylation of the primary hydrazine nitrogen

What is the principal inactivation pathway of isoniazid?

37
New cards

- Peripheral Neuritis
- Gastrointestinal Disturbances
- Hepatoxicity

TOXIC REACTIONS OF ISONIAZID

38
New cards

Rifampicin/ Rifampin

Antitubercular Agents: 1st Line
- The most active agent in clinical use for the treatment of tuberculosis
- However, resistance to this drug develops rapidly in most species of bacteria, including the tubercle bacillus

<p><strong><em>Antitubercular Agents: 1st Line</em></strong><br>- The most active agent in clinical use for the treatment of tuberculosis <br>- However, resistance to this drug develops rapidly in most species of bacteria, including the tubercle bacillus</p>
39
New cards

binds to the B-subunit of bacterial DNA-dependent RNA polymerases to prevent chain initiation

MOA of Rifampicin

40
New cards

Because it induces CYP450 enzymes, reducing the effectiveness of these drugs.

Why should rifampin not be combined with oral anticoagulants, benzodiazepines, or theophylline?

41
New cards

Reddish-orange discoloration of urine, stool, saliva, tears, and skin.

What unusual bodily fluid discoloration can occur with rifampin use?

42
New cards

Due to its hepatotoxicity, which may worsen liver function in alcoholics.

Why should rifampin not be used in chronic alcoholics?

43
New cards

Pyrazinamide

Antitubercular Agents: 1st Line
- Has recently been elevated to first-line status in short-term tuberculosis treatment regimens because of its tuberculocidal activity and comparatively low short-term toxicity
- Not active against metabolically inactive tubercle bacilli (not considered suitable for long-term therapy)
- Maximally effective in the low pH environment that exists in macrophages
- 12-24 hours, allowing once-daily or twice-weekly dosing.

<p><strong><em>Antitubercular Agents: 1st Line</em></strong><br>- Has recently been elevated to first-line status in short-term tuberculosis treatment regimens because of its tuberculocidal activity and comparatively low short-term toxicity <br>- Not active against metabolically inactive tubercle bacilli (not considered suitable for long-term therapy) <br>- Maximally effective in the low pH environment that exists in macrophages<br>- 12-24 hours, allowing once-daily or twice-weekly dosing.</p>
44
New cards

Penetrates Inflamed Meninges

Why is pyrazinamide recommended for tuberculous meningitis?

45
New cards

It interferes with uric acid excretion.

Why should pyrazinamide be used cautiously in patients with hyperuricemia or gout?

46
New cards

Pyrazinamide

Which TB drug in the HRZE/S regimen is the most hepatotoxic?

47
New cards

Ethambutol

Antitubercular Agents: 1st Line
- Active only against dividing mycobacteria
- Has no effect on encapsulated or other nonproliferating forms
- not recommended for use alone, but in combinations with other antitubercular drugs in the chemotherapy of pulmonary tuberculosis

<p><strong><em>Antitubercular Agents: 1st Line</em></strong><br><em>- A</em>ctive only against dividing mycobacteria <br>- Has no effect on encapsulated or other nonproliferating forms<br>- not recommended for use alone, but in combinations with other antitubercular drugs in the chemotherapy of pulmonary tuberculosis</p>
48
New cards

Inhibits the incorporation of mycolic acid into the cell wall.

MOA of Ethambutol

49
New cards

Red-green color blindness

Adverse Effect of Ethambutol

50
New cards

Ethambutol

Which HRZE/S drug is the only bacteriostatic agent?

51
New cards

Streptomycin

Antitubercular Agents: 1st Line
- Produced from Streptomyces griseus
- MOA: inhibits the 30s bacterial ribosomal subunit
- Adverse effect: nephrotoxicity, vestibulotoxicity

<p><strong><em>Antitubercular Agents: 1st Line</em></strong><br>- Produced from Streptomyces griseus <br>- MOA: inhibits the 30s bacterial ribosomal subunit <br>- Adverse effect: nephrotoxicity, vestibulotoxicity</p>
52
New cards

Streptomyces griseus

Streptomycin is produced from which organism?

53
New cards

It inhibits the 30s bacterial ribosomal subunit, preventing protein synthesis.

What is the mechanism of action (MOA) of streptomycin?

54
New cards

- Nephrotoxicity (kidney damage).
- Vestibulotoxicity (damage to the inner ear, affecting balance).

What are the two major adverse effects of streptomycin?

55
New cards

Kanamycin

Antitubercular Agents: 2nd Line
- produced from Streptomyces kanamyceticus
- MOA: inhibits the 30s bacterial ribosomal subunit
- Adverse effect: nephrotoxicity, vestibulotoxicity

<p><strong><em>Antitubercular Agents: 2nd Line</em></strong><br>- produced from Streptomyces kanamyceticus<br>- MOA: inhibits the 30s bacterial ribosomal subunit<br>- Adverse effect: nephrotoxicity, vestibulotoxicity</p>
56
New cards

Ethionamide

Antitubercular Agents: 2nd Line
- Has weak bacteriostatic activity in vitro but, because of its lipid solubility, is effective in vivo
- Used in the treatment of isoniazid-resistant tuberculosis
- Highest tolerated dose of this drug is usually recommended due to low potency

<p><strong><em>Antitubercular Agents: 2nd Line</em></strong><br>- Has weak bacteriostatic activity in vitro but, because of its lipid solubility, is effective in vivo <br>- Used in the treatment of<strong><em> isoniazid-resistant tuberculosis </em></strong><br>- Highest tolerated dose of this drug is usually recommended due to low potency</p>
57
New cards

GI intolerance
Hepatotoxicity
Visual disturbances

Adverse Effect of Ethionamide

58
New cards

Para-aminosalicylic Acid (PAS)

Antitubercular Agents: 2nd Line
- Orally in the form of its sodium salt, usually as a tablet or capsule.
- Similar to sulfonamides → Prevents the incorporation of PABA into dihydrofolic acid, catalyzed by dihydrofolate synthetase.
- used to be a first-line drug until the introduction of more effective agents

<p><strong><em>Antitubercular Agents: 2nd Line</em></strong><br>- Orally in the form of its sodium salt, usually as a tablet or capsule.<br>- Similar to sulfonamides → Prevents the incorporation of PABA into dihydrofolic acid, catalyzed by dihydrofolate synthetase.<br>- used to be a first-line drug until the introduction of more effective agents</p>
59
New cards

Aminosalicylic acid
4-aminosalicylic acid
PAS

What are the alternative names for para-aminosalicylic acid?

60
New cards

The amino and carboxyl groups must be para to each other and free.

What structural feature is required for PAS activity?

61
New cards

Dihydrofolic Acid

Para-aminosalicylic acid (PAS) prevents the incorporation of PABA into what molecule?

62
New cards

Cycloserine

Antitubercular Agents: 2nd Line
- Isolated from the fermentation beer of S. orchidaceus, S. garyphalus, and S. lavendulus
- MOA: prevents the synthesis of cross-linking peptide in the formation of bacterial cell walls
- Recommended for patients who fail to respond to other tuberculostatic drugs or who are known to be infected with organisms resistant to other agents

<p><strong><em>Antitubercular Agents: 2nd Line</em></strong><br>- Isolated from the fermentation beer of S. orchidaceus, S. garyphalus, and S. lavendulus <br>- MOA: prevents the synthesis of cross-linking peptide in the formation of bacterial cell walls<br>- Recommended for patients who fail to respond to other tuberculostatic drugs or who are known to be infected with organisms resistant to other agents</p>
63
New cards

Streptomyces orchidaceus
S. garyphalus
S. lavendulus

Cycloserine is isolated from which organisms?

64
New cards

Prevents the synthesis of cross-linking peptide in the formation of bacterial cell walls.

What is the MOA of cycloserine?

65
New cards

Capreomycin

Antitubercular Agents: 2nd Line
- Isolated from Streptomyces capreolus
- May be used in place of streptomycin when either the patient is sensitive or the strain of M. tuberculosis is resistant to streptomycin

<p><strong><em>Antitubercular Agents: 2nd Line</em></strong><br>- Isolated from Streptomyces capreolus<br>- May be used in <strong><em>place of streptomycin</em></strong> when either the patient is sensitive or the strain of M. tuberculosis is resistant to streptomycin</p>
66
New cards

Dapsone
Clofazimine

Anti-leprosy Agents

67
New cards

Dapsone

Anti-leprosy Agents
- Used in the treatment of both lepromatous and tuberculoid types of leprosy
- Drug of choice for dermatitis herpetiformis
- Adverse effects: hemolytic anemia, methemoglobinemia, hepatotoxicity

<p><strong><em>Anti-leprosy Agents</em></strong><br>- Used in the treatment of both lepromatous and tuberculoid types of leprosy<br>- Drug of choice for dermatitis herpetiformis<br>- Adverse effects: hemolytic anemia, methemoglobinemia, hepatotoxicity</p>
68
New cards

Clofazimine
Rifampicin

Dapsone is used in combination with which drugs for leprosy treatment?

69
New cards

Risk of severe hemolysis.

Why should dapsone not be administered to G6PD-deficient patients?

70
New cards

- Pyrimethamine for malaria
- Trimethoprim for PCP

Dapsone is sometimes combined with which drugs for malaria and PCP treatment?

71
New cards

Clofazimine

Anti-leprosy Agents
- Used in the treatment of lepromatous leprosy, including dapsone-resistant forms
- Frequently used in combination with other drugs, such as dapsone or rifampicin
- Has anti-inflammatory and immune-modulating effects that are of value in controlling neuritic complications and in suppressing erythema nodosum leprosum reactions
- Binds to nucleic acids and concentrates in reticuloendothelial tissue
- May interfere with electron transport processes by being an electron acceptor

<p><strong><em>Anti-leprosy Agents</em></strong><br>- Used in the treatment of lepromatous leprosy, including dapsone-resistant forms <br>- Frequently used in combination with other drugs, such as dapsone or rifampicin<br>- Has anti-inflammatory and immune-modulating effects that are of value in controlling neuritic complications and in suppressing erythema nodosum leprosum reactions<br>- Binds to nucleic acids and concentrates in reticuloendothelial tissue <br>- May interfere with electron transport processes by being an electron acceptor</p>
72
New cards

Erythema nodosum leprosum reactions.

What leprosy-related reaction does clofazimine help suppress?